Van Eck Associates Corp Bausch Health Companies Inc. Transaction History

Van Eck Associates Corp

  • $88.3 Billion
  • Q2 2025

A detailed history of Van Eck Associates Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 131,226 shares of BHC stock, worth $867,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
131,226
Previous 467,152 71.91%
Holding current value
$867,403
Previous $3.02 Million 71.08%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$4.32 - $6.66 $1.45 Million - $2.24 Million
-335,926 Reduced 71.91%
131,226 $874,000
Q1 2025

May 15, 2025
BUY
$6.16 - $7.94 $1.5 Million - $1.94 Million
243,732 Added 109.09%
467,152 $3.02 Million
Q4 2024

Jan 29, 2025
SELL
$7.34 - $9.78 $879,684 - $1.17 Million
-119,848 Reduced 34.91%
223,420 $1.8 Million
Q3 2024

Oct 29, 2024
BUY
$5.22 - $8.26 $212,960 - $336,983
40,797 Added 13.49%
343,268 $2.77 Million
Q2 2024

Jul 31, 2024
BUY
$6.1 - $10.41 $69,411 - $118,455
11,379 Added 3.91%
302,471 $2.11 Million
Q1 2024

Apr 30, 2024
SELL
$7.77 - $10.61 $733,425 - $1 Million
-94,392 Reduced 24.49%
291,092 $3.09 Million
Q4 2023

Feb 05, 2024
SELL
$6.53 - $8.23 $782,117 - $985,731
-119,773 Reduced 23.71%
385,484 $3.09 Million
Q3 2023

Nov 08, 2023
SELL
$7.69 - $9.71 $809,749 - $1.02 Million
-105,299 Reduced 17.25%
505,257 $4.15 Million
Q2 2023

Aug 03, 2023
BUY
$5.72 - $8.8 $1.45 Million - $2.24 Million
254,075 Added 71.27%
610,556 $4.88 Million
Q1 2023

May 03, 2023
SELL
$6.28 - $9.85 $1.89 Million - $2.96 Million
-301,015 Reduced 45.78%
356,481 $2.89 Million
Q4 2022

Feb 08, 2023
BUY
$6.09 - $7.93 $594,993 - $774,761
97,700 Added 17.45%
657,496 $4.13 Million
Q3 2022

Oct 27, 2022
SELL
$4.58 - $9.21 $927,381 - $1.86 Million
-202,485 Reduced 26.56%
559,796 $3.86 Million
Q2 2022

Aug 03, 2022
BUY
$7.06 - $23.63 $2.24 Million - $7.51 Million
317,964 Added 71.56%
762,281 $6.37 Million
Q1 2022

May 10, 2022
BUY
$21.6 - $27.79 $422,301 - $543,322
19,551 Added 4.6%
444,317 $10.2 Million
Q4 2021

Jan 26, 2022
BUY
$23.0 - $29.01 $1.9 Million - $2.4 Million
82,819 Added 24.22%
424,766 $11.7 Million
Q3 2021

Nov 03, 2021
BUY
$25.04 - $30.06 $2.39 Million - $2.87 Million
95,547 Added 38.78%
341,947 $9.52 Million
Q2 2021

Aug 10, 2021
SELL
$27.43 - $32.7 $5.81 Million - $6.93 Million
-211,849 Reduced 46.23%
246,400 $7.23 Million
Q1 2021

May 13, 2021
BUY
$21.37 - $34.38 $2.01 Million - $3.23 Million
94,057 Added 25.83%
458,249 $14.5 Million
Q4 2020

Feb 09, 2021
BUY
$15.31 - $21.12 $121,148 - $167,122
7,913 Added 2.22%
364,192 $7.58 Million
Q3 2020

Nov 12, 2020
SELL
$14.88 - $20.13 $467,827 - $632,887
-31,440 Reduced 8.11%
356,279 $5.54 Million
Q2 2020

Aug 10, 2020
BUY
$13.31 - $20.51 $610,782 - $941,183
45,889 Added 13.42%
387,719 $7.09 Million
Q1 2020

May 12, 2020
BUY
$12.98 - $30.25 $790,702 - $1.84 Million
60,917 Added 21.69%
341,830 $5.3 Million
Q4 2019

Feb 13, 2020
BUY
$18.89 - $31.89 $910,762 - $1.54 Million
48,214 Added 20.72%
280,913 $8.41 Million
Q3 2019

Nov 08, 2019
SELL
$20.88 - $25.66 $2.61 Million - $3.21 Million
-125,116 Reduced 34.97%
232,699 $5.08 Million
Q2 2019

Aug 07, 2019
BUY
$20.52 - $26.45 $43,543 - $56,126
2,122 Added 0.6%
357,815 $9.02 Million
Q1 2019

May 13, 2019
SELL
$20.23 - $26.29 $2.21 Million - $2.87 Million
-109,222 Reduced 23.49%
355,693 $8.79 Million
Q4 2018

Feb 12, 2019
SELL
$17.64 - $28.32 $891,966 - $1.43 Million
-50,565 Reduced 9.81%
464,915 $8.59 Million
Q3 2018

Nov 13, 2018
BUY
$20.64 - $25.67 $431,252 - $536,348
20,894 Added 4.22%
515,480 $13.2 Million
Q2 2018

Aug 13, 2018
BUY
$15.07 - $26.86 $7.45 Million - $13.3 Million
494,586 New
494,586 $11.5 Million

Others Institutions Holding BHC

# of Institutions
253
Shares Held
240M
Call Options Held
2.46M
Put Options Held
8.42M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.39B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email